Search

Laboratorios Farmaceuticos Rovi SA

Closed

SectorHealthcare

60.05 0.67

Overview

Share price change

24h

Current

Min

59.65

Max

60.9

Key metrics

By Trading Economics

Income

80M

89M

Sales

39M

192M

P/E

Sector Avg

15.912

57.371

EPS

1.466

Dividend yield

1.66

Profit margin

46.582

Employees

2,470

EBITDA

83M

101M

Dividends

By Acuity

Dividend yield

Sector Avg

1.66%

2.23%

Next Earnings

5 lis 2026

Market Stats

By TradingEconomics

Market Cap

171M

2.9B

Previous open

59.38

Previous close

60.05

News Sentiment

By Acuity

59%

41%

303 / 340 Ranking in Healthcare

Laboratorios Farmaceuticos Rovi SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

20 sie 2026, 23:11 UTC

News

Hawaiian Electric Industries has restored power to all customers in Oahu and Maui after Hurricane Lala, with shares trading higher in after-market hours.

20 sie 2026, 23:06 UTC

News

Eaton Corporation shares are trading higher in after-market hours following coverage initiation by BMO and Baird analysts, who both assigned an Outperform rating.

20 sie 2026, 23:06 UTC

News

After-market shares of Interactive Brokers Group Inc are higher as client margin loan balances rose to $100.7 billion in July, a 49% year-over-year increase.

20 sie 2026, 23:06 UTC

Correlated Moves
ETF Constituents
News

Vanguard Small-Cap ETF trades roughly flat since Thursday's close.

20 sie 2026, 23:06 UTC

News
Correlated Moves

Royal Caribbean Cruises has completed a $1.25 billion public offering of senior unsecured notes, with shares trading higher in after-market hours.

20 sie 2026, 23:06 UTC

News

Nextera Energy has secured funding agreements for up to 10 gigawatts of gas generation, supporting cash flow expectations as shares trade higher after market hours.

20 sie 2026, 23:06 UTC

Correlated Moves
News

Doubts about Treasury Secretary Bessent's bond-buyback plans pressure the bond market. The iShares 20+ Year Treasury Bond ETF is little changed in after-market hours.

20 sie 2026, 23:06 UTC

News

Iovance Biotherapeutics reached a 52-week high after UBS raised its target price to $7, noting strong second-quarter sales of $91 million.

20 sie 2026, 23:01 UTC

News
Social Media

Boston Beer Company shares decline in after-market hours following CFO transition announcement. Broader market pressure stems from losses in major companies like Walmart Inc.

20 sie 2026, 23:01 UTC

News
Social Media
Event

Ross Stores reported second-quarter net income of $851.3 million and raised fiscal year 2026 EPS guidance, driving shares higher in after-market trading.

20 sie 2026, 23:01 UTC

News

Fiserv Inc. is higher in after-market trading following its selection by Flagstar Bank for a modernization project and a partnership with Thunes.

20 sie 2026, 23:01 UTC

Event
News

Flowers Foods Inc shares declined in after-market hours following disappointing second-quarter results and a lowered full-year sales guidance. Net income dropped 30.3% to $40.7 million.

20 sie 2026, 23:01 UTC

News

Photronics Inc. shares are lower in after-market trading, reflecting broader market declines amid significant losses from major companies like Walmart Inc.

20 sie 2026, 23:01 UTC

News

Boeing Co secured $173.8 million in contracts from the U.S. Department of Defense, contributing to shares trading higher in after-market hours.

20 sie 2026, 23:01 UTC

News
Event

Prospect Capital Corp reported net investment income of $77.7 million, but shares are lower in after-market hours amid broader market pressures.

20 sie 2026, 23:01 UTC

News

Doubts over Treasury Secretary Bessent's bond-buyback plans weigh on the market. iShares Core U.S. Aggregate Bond ETF is trading higher in after-market hours.

20 sie 2026, 23:01 UTC

News

The iShares 7-10 Year Treasury Bond ETF is trading higher after-hours amid doubts about Treasury Secretary Bessent's bond-buyback plans to reduce borrowing costs.

20 sie 2026, 23:01 UTC

News

Abercrombie & Fitch Co. appointed Mary Fox to its Board of Directors, effective August 18, 2026. Shares are trading higher in after-market hours.

20 sie 2026, 23:01 UTC

News

Abbott Laboratories settles litigation for $670 million over preterm infant formulas, trading lower in after-market hours following the news.

20 sie 2026, 22:51 UTC

News

Deere & Co shares rise in after-market hours following strong fiscal Q3 results, with net income up to $1.38 billion and raised full-year guidance.

20 sie 2026, 22:41 UTC

News

EHang Holdings appointed KPMG Huazhen LLP as its new auditor, effective August 19, 2026. Shares are trading higher in after-market hours.

20 sie 2026, 22:36 UTC

News

Evolution Petroleum Corp has acquired Midland Basin interests for $16 million, expected to generate $3.9 million in cash flow over the next year. Shares are trading higher after hours.

20 sie 2026, 22:01 UTC

News

American Homes 4 Rent declared a quarterly dividend of $0.33 per share, contributing to a modest increase in after-market hours trading.

20 sie 2026, 22:01 UTC

News

Sysco Corporation announced a quarterly dividend of $0.55 per share, payable October 23, 2026. Shares are trading higher in after-market hours.

20 sie 2026, 21:01 UTC

News

Andersons Inc declared a quarterly cash dividend of $0.20 per share, scheduled for payment on October 22, boosting shares higher in after-market trading.

20 sie 2026, 21:01 UTC

News

HNI Corp's board approved an additional $200 million for its share repurchase program, boosting shares in after-market trading.

20 sie 2026, 21:01 UTC

News

Murphy USA announced its Just Baked autonomous foodservice platform with White Castle, but shares are trading lower in after-market hours.

20 sie 2026, 20:07 UTC

News

NACCO Industries declared a quarterly dividend of $0.2625 per share. Shares are trading lower amid rising crude oil prices and U.S. Treasury yields.

20 sie 2026, 20:07 UTC

News
Correlated Moves

Cars.com shares are lower following the sale of 57,980 shares by Chief Legal Officer Angelique Strong Marks, valued at $692,281.

20 sie 2026, 20:07 UTC

Social Media
News

Meta Platforms Inc. shares are slightly lower at $545.00 amid mixed options sentiment and light trading volume, with analysts noting growth potential in AI investments.

Peer Comparison

Price change

Laboratorios Farmaceuticos Rovi SA Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Sentiment

By Acuity

303 / 340 Ranking in Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
help-icon Live chat